The issue price was at the upper end of the valuation, which may have capped demand and gains on listing.
Listed insurance company’s interim profit down after four large weather events during the half.
However, the listed meal company is having to mitigate inflated cost pressures.
The listed used car dealer reintroduces a ‘tough macro’ approach to keep a lid on costs and its buying approach.
The largest locally-owned pharma has delivered double-digit revenue growth and record earnings for FY26.
Stride scoops fees of $8 million on ‘enhanced project activity’, generated by selling its Silverdale Centre to a company it manages.
The NZ cervical cancer screening device company reported an unaudited FY26 loss of $2.2m.
Regulatory hurdles including an investigation into the impact on competition could push the handover of the New Zealand division out by months.
Serko and Napier Port rallied on small earnings beats.
The NZX-listed port and economic bellwether has posted a strong set of interim financial results, amid the primary sector doing well.